The initial success of Viagra undeniably revolutionized the medication landscape, but betting in companies heavily reliant on generic versions presents a complex picture. Although early earnings were substantial, the cessation of patents and the rise of cheaper alternatives have weakened the customer base. Therefore, a thorough evaluation of ongoin